Copyright
©The Author(s) 2019.
World J Clin Cases. Sep 6, 2019; 7(17): 2505-2512
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2505
Published online Sep 6, 2019. doi: 10.12998/wjcc.v7.i17.2505
Authors | Sex | Average age | Serum angiotensin-converting enzyme | Chest X-ray | Most common site of lesion | Most common site of systemic involvement other than the lungs |
Ahmed et al[14], 2006 | 15F/6M | 46.3 | 3/11 Elevated | 9/16 Lymphadenopathy, 6/16 Pulmonary infiltration | Upper extremities | Joints-arthritis |
Ando et al[15], 2016 | 8F/1M | 52.5 | 7/9 Elevated | 3/9 Lymphadenopathy, 6/9 Lymphadenopathy with pulmonary infiltration | Upper extremities | Eyes |
Marcoval et al[7], 2005 | 9F/1M | 52.6 | NA | 8/10 Lymphadenopathy, 1/10 Lymphadenopathy with pulmonary infiltration | Upper extremities | NA |
Marcoval et al[3], 2011 | 11F/3M | N/A | NA | 11/14 Lymphadenopathy, 2/14 Lymphadenopathy with pulmonary infiltration | Upper and lower extremities | Joints-arthritis |
Authors | Sex | Average age | Serum angiotensin-converting enzyme | Chest computed tomography | Chest X-ray | Site of lesion | Extracutaneous involvement other than the lungs |
Barnadas et al[16], 2000 | F | 38 | Normal | Normal | Normal | Upper and lower limbs | Malaise, joint pains |
Girão et al[17], 2000 | M | 37 | Elevated | Lymphadenopathy | Lower limb | Hands and feet arthralgia | |
Dalle Vedove et al[18], 2011 | 1F/1M | 75 | 2/2 Elevated | 1/2 Mediastinal Lymphadenopathy, 1/2 Lymphadenopathy with pulmonary infiltration | 2/2 Normal | Upper and lower limbs | 1/2 Uveitis |
Kim et al[19], 2014 | M | 61 | Elevated | Normal | Trunk | Renal | |
Fichtel et al[20], 2006 | F | 42 | Elevated | Normal | Upper and lower limbs | None | |
Bosnic et al[21], 2010 | F | 51 | Elevated | Normal | Face | None | |
Kim et al[22], 2017 | M | 33 | Lymphadenopathy with pulmonary infiltration | Face, toe | None | ||
Won et al[23], 2016 | F | 54 | Normal | Lower limb | None | ||
Marcoval et al[24], 2008 | F | 49 | Elevated | Lymphadenopathy | Upper and lower limbs | None | |
Dulgueroy et al[25], 2015 | F | 34 | Elevated | Lymphadenopathy with pulmonary infiltration | Face | None | |
Ruangchaijatuporn et al[26], 2016 | M | 56 | Normal | Lower limb | None | ||
Watanbe et al[27], 2007 | F | 70 | Elevated | Lymphadenopathy | Lower limb | Polyneuropathy of limbs | |
Janegova et al[28], 2016 | F | 59 | Lymphadenopathy with pulmonary infiltration | Foot | None | ||
Yamaguchi et al[29], 2013 | F | 85 | Elevated | Lymphadenopathy with pulmonary infiltration | Lymphadenopathy | Upper and lower limbs | Joints arthralgia |
Mori et al[30], 2018 | F | 72 | Elevated | Lower limb | Renal and cardiac dysfunction | ||
Kwan et al[31], 2015 | F | 53 | Elevated | Lymphadenopathy | Upper and lower limbs | None | |
Miida et al[32], 2009 | F | 62 | Elevated | Lymphadenopathy with pulmonary infiltration | Lymphadenopathy | Upper limbs | Uveitis, renal dysfunction, splenic nodules |
Bianchini et al[33], 2010 | F | 38 | Elevated | Normal | Normal | Face | None |
Kerner et al[34], 2008 | F | 53 | Lymphadenopathy | Lymphadenopathy | Upper and lower limbs | Facial nerve palsy, arthralgia | |
Kim et al[35], 2013 | F | 52 | Elevated | Lymphadenopathy with pulmonary infiltration | Lymphadenopathy | Upper and lower limbs | None |
Guccione et al[36], 2017 | M | 40 | Lymphadenopathy | Upper limbs, trunk | None | ||
Meyer-Gonzalez et al[37], 2011 | 3F | 52.6 | 1/3 Normal, 2/3 Elevated | 1/3 Lymphadenopathy, 2/3 Lymphadenopathy with pulmonary infiltration | 3/3 Lymphadenopathy | Upper and lower limbs | Dactylitis, lower limb weakness |
Moscatelli et al[38], 2011 | M | 41 | Lymphadenopathy with pulmonary infiltration | Normal | Hand | None | |
Shigemitsu et al[39], 2008 | F | 65 | Lymphadenopathy | Upper extremity | None | ||
Celik et al[40], 2010 | F | 53 | Elevated | Lymphadenopathy with pulmonary infiltration | Lymphadenopathy | Foot | None |
- Citation: Mehrzad R, Festa J, Bhatt R. Subcutaneous sarcoidosis of the upper and lower extremities: A case report and review of the literature. World J Clin Cases 2019; 7(17): 2505-2512
- URL: https://www.wjgnet.com/2307-8960/full/v7/i17/2505.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v7.i17.2505